Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Immunogen
Immunogen
Here's why ImmunoGen's CEO is psyched for combo tests with Keytruda
Bizjournals.com
Thu, 02/4/16 - 09:36 am
Merck
Immunogen
Keytruda
maytansine
Dan Junius
ImmunoGen Refines Drug Targeting for Ovarian Cancer Patients
TheStreet.com
Mon, 11/9/15 - 09:33 am
Immunogen
ovarian cancer
mirvetuximab soravtansin
clinical trials
ImmunoGen, Inc. Pushes Its Pipeline Forward
Motley Fool
Sat, 10/31/15 - 10:05 am
Immunogen
ImmunoGen, Roche gastric cancer drug fails study
Yahoo/Reuters
Thu, 10/22/15 - 09:54 am
Immunogen
Roche
gastric cancer
clinical trials
Kadcyla
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
biotech
ASCO
Immunogen
Exelixis
Oncothyreon
CTI BioPharma
Immunomedics
Vascular Biogenics
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
ASCO
Ignyta
Immunogen
Puma Biotechnology
AbbVie
Roche
Bristol-Myers Squibb
Seattle Genetics
Juno Therapeutics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
ASCO
Immunogen
mirevtuximab soravtansine
ONT-380
Oncothyreon
cabozantinib
Exelixis
VB-111
Vascular Biogenics
Immunomedics
sacituzumab govitecan
pacritinib
CTI BioPharma
Sanofi dumps an ImmunoGen cancer drug as it scales back in oncology
Fierce Biotech
Sat, 04/25/15 - 08:33 am
Sanofi
Immunogen
SAR3419
diffuse large B-cell lymphoma
ImmunoGen beats Street 2Q forecasts
Yahoo/AP
Fri, 01/30/15 - 01:15 pm
Immunogen
earnings
Earnings Peek: ImmunoGen Is Undervalued
Seeking Alpha
Mon, 01/26/15 - 10:25 am
Immunogen
earnings
ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline
Yahoo/BusinessWire
Sun, 01/11/15 - 09:44 am
Immunogen
ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition
Yahoo/BusinessWire
Sun, 12/7/14 - 09:49 am
Immunogen
IMGN529
B-cell lymphoma
Novartis takes three licenses to ImmunoGen drug targets
Seeking Alpha
Tue, 10/7/14 - 11:19 am
Novartis
Immunogen
ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance
Yahoo/Zacks.com
Mon, 08/4/14 - 02:53 pm
Immunogen
earnings
3 Biotech Stocks Breaking Out on Big Volume
TheStreet.com
Mon, 07/21/14 - 10:36 am
Ultragenyx
Bluebird Bio
Immunogen
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations
Seeking Alpha
Sun, 01/26/14 - 10:41 am
Seattle Genetics
Immunogen
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Fri, 12/27/13 - 01:08 pm
cancer
Roche
Infinity Pharmaceuticals
Inovio
Immunogen
Gilead Sciences
immunotherapy
antibody-drug conjugate
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Ziopharm
cancer
AbbVie
Amgen
Celgene
Celldex Therapeutics
Gilead Sciences
Immunogen
JNJ
ImmunoCellular Therapeutics
Pharmacyclics
Intrexon
Seattle Genetics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »